United States News Todas as matérias

Third Coast Bancshares (NYSE:TCBX) completed the sale of substantially all assets of its subsidiary Third Coast Commercial Capital to Gulf Coast Bank & Trust for approximately $27.5 million, generating a $3.5 million gain.

Aethlon Medical (NASDAQ:AEMD) reported that patients in the second cohort of its oncology feasibility study exhibited biological changes.

Diana Shipping (NYSE:DSX) extended its tender offer to acquire all outstanding shares of Genco Shipping & Trading (NYSE:GNK) it does not already own through July 24, 2026, after shareholders tendered 11.08 million shares.

Greenfire Resources (NYSE:GFR) agreed to acquire private thermal oil sands producer Connacher Oil and Gas for an estimated C$1.277 billion in cash, net of expected closing adjustments, expanding its production base and reserves position.

The Metals Royalty Company (NASDAQ:TMC) reported that its Mesabi Metallics iron ore royalty project in Nashwauk, Minnesota completed its first production blast on July 10, 2026, marking a step toward planned pellet production.

Ocugen (NASDAQ:OCGN) signed a binding term sheet with Roots Pharmaceutical and strategic partner Al-Dhow International Holding to negotiate an exclusive license for OCU400, its investigational modifier gene therapy for retinitis pigmentosa, across the Middle East and North Africa region.

Alkermes (NASDAQ:ALKS) reported interim results from its ongoing long-term extension study of alixorexton in adults with narcolepsy type 1 and narcolepsy type 2, showing sustained improvements in wakefulness, sleepiness and patient-reported outcomes after 24 weeks.

Ionis Pharmaceuticals (NASDAQ:IONS) announced that the first participant has been dosed in the Phase 1-2 ASCEND study evaluating ION337, an investigational RNA-targeted medicine for children with Dravet syndrome, a rare neurological disorder.

Bristol Myers Squibb (NYSE:BMY) announced that the U.S. Food and Drug Administration accepted its New Drug Application for mezigdomide in combination with carfilzomib and dexamethasone, known as MeziKd, for patients with relapsed or refractory multiple myeloma.

Q32 Bio (NASDAQ:QTTB) reported positive 36-week topline results from Part B of the Phase 2a SIGNAL-AA trial evaluating bempikibart in 33 patients with severe or very severe alopecia areata.

ANI Pharmaceuticals (NASDAQ:ANIP) reported positive six-month topline results from the Phase 4 SYNCHRONICITY trial evaluating fluocinolone acetonide intravitreal implant 0.18 mg in 108 patients with chronic non-infectious uveitis affecting the posterior segment.

Brightstar Lottery (NYSE:BRSL) announced that its subsidiary Brightstar Global Solutions received a seven-year contract extension to continue as the primary technology supplier for Washington’s Lottery through June 30, 2036.

Lazard (NYSE:LAZ) reported preliminary assets under management of approximately $284.7 billion as of June 30, 2026, reflecting market gains, currency movements and the acquisition of a controlling interest in Elaia Partners.

GSK (NYSE:GSK) reported positive interim results from the Phase II AZUR-1 trial of Jemperli (dostarlimab) in patients with stage II/III mismatch repair deficient or microsatellite instability-high locally advanced rectal cancer, with the study meeting its primary objective.

Meta Platforms (NASDAQ:META) announced that its data center in Richland Parish, Louisiana will expand to 5 gigawatts of computing capacity as the company increases infrastructure supporting its artificial intelligence development.

Emera (NYSE:EMA) declared quarterly dividends on its common shares and First Preferred Shares, including a payment of $0.7325 per common share scheduled for August 17, 2026.

Northern Oil and Gas (NYSE:NOG) reported second-quarter business updates, including estimated derivative gains of $155 million to $160 million, share repurchases of 2.95 million shares and an expanded share repurchase authorization of approximately US$243 million.

Incyte (NASDAQ:INCY) reported complete Phase 1/2 safety and efficacy data from 16 patients treated with latarcibart, an investigational Protein S-targeting antibody being developed for von Willebrand disease (VWD).

Taiwan Semiconductor Manufacturing Company (NYSE:TSM) reported second-quarter revenue of T$1.27 trillion (US$39.62 billion), up 36% from a year earlier, as demand for artificial intelligence applications supported growth.

Takeda (NYSE:TAK) and the Indonesian Government announced a landmark multi-year collaboration to enhance domestic health resilience and access to lifesaving therapies.

Stellantis (NYSE:STLA) announced estimated consolidated shipments of 1.6 million vehicles for the three months ending June 30, 2026.

Brent crude futures rose 4% to above $79 per barrel in Asian trading after renewed U.S.-Iran tensions and claims of disruption around the Strait of Hormuz increased concerns about global oil supply.

Ferguson Enterprises (NYSE:FERG) agreed to acquire FWI Holdings, the parent company of FloWorks, from Wynnchurch Capital in a cash transaction valuing FloWorks at approximately $1.6 billion in enterprise value.

Genco Shipping & Trading (NYSE:GNK) rejected a $24.80 per share offer from Diana Shipping (NYSE:DSX), stating it undervalues the business.